Novartis | Despesas Operacionais



Operating Expenses Alterar Data
AbbVie USD 9.61B 6.98B 2025-03
Amgen USD 6.86B 85M 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bausch Health Companies USD 1.98B 32M 2025-03
Biogen USD 2.12B 106.5M 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 153.8M 2.83M 2025-03
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Glaxosmithkline GBP 7.42B 408M 2024-12
Indivior 200M 193M 2025-03
J&J USD 8.26B 10.37B 2025-03
Merck USD 9.66B 1.67B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Pacira USD 166.93M 4.38M 2025-03
Perrigo USD 964.5M 61.1M 2025-03
Pfizer USD 10.05B 8.12B 2025-03
Prestige Brands USD 208.09M 9.74M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
Sanofi EUR 6.77B 3.75B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
Zoetis USD 1.41B 175M 2025-03



Novartis Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2025.